|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| (Gain)/loss on sale of investments | |||||
| Net (gain)/loss on sale of assets | |||||
| Mortgage banking activity | |||||
| Gain on sale of SBA loans | |||||
| Gain on sale of mortgage servicing rights | |||||
| Gain on sale of loans | |||||
| Gain on sale of insurance business | |||||
| Net depreciation, amortization and accretion | |||||
| Increase in other assets | |||||
| Increase in other liabilities | |||||
| Net amortization on marketable securities | |||||
| Noncash compensation expense related to stock benefit plans | |||||
| Noncash write-down of real estate owned | |||||
| Deferred income tax (benefit)/expense | |||||
| Origination of loans held-for-sale | |||||
| Proceeds from sale of loans held-for-sale | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Purchase of marketable securities held-to-maturity | |||||
| Purchase of marketable securities available-for-sale | |||||
| Proceeds from maturities and principal reductions of marketable securities held-to-maturity | |||||
| Proceeds from maturities and principal reductions of marketable securities available-for-sale | |||||
| Proceeds from sale of marketable securities available-for-sale | |||||
| Proceeds from bank-owned life insurance | |||||
| Proceeds from sale of mortgage servicing rights | |||||
| Loan originations | |||||
| Loan purchases | |||||
| Proceeds from loan maturities and principal reductions | |||||
| Net redemptions of FHLB stock | |||||
| Proceeds from sale of real estate owned | |||||
| Proceeds from sale of real estate owned for investment, net | |||||
| Purchases of premises and equipment, net | |||||
| Proceeds from sale of insurance business | |||||
| Acquisitions, net of cash received | |||||
| Net cash (used in)/provided by investing activities | |||||
| Financing activities: | |||||
| Net increase in deposits | |||||
| Repayments of long-term borrowings | |||||
| Net decrease in short-term borrowings | |||||
| Decrease in advances by borrowers for taxes and insurance | |||||
| Cash dividends paid on common stock | |||||
| Proceeds from stock options exercised | |||||
| Purchase of common stock for retirement | |||||
| Net cash (used in)/provided by financing activities | |||||
| Net (decrease)/increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental cash flow information: | |||||
| Cash paid during the period for: | |||||
| Interest on deposits and borrowings (including interest credited to deposit accounts of $200,661, $170,754, and $86,316, respectively) | |||||
| Income taxes | |||||
| Business acquisitions: | |||||
| Fair value of assets acquired | |||||
| Northwest Bancshares, Inc. common stock issued | |||||
| Net cash paid | |||||
| Liabilities assumed | |||||
| Noncash activities: | |||||
| Loan foreclosures and repossessions | |||||
| Sale of real estate owned financed by the Company | |||||
Loading...
